Organon & Co.

OGN

Healthcare Drug Manufacturers General

Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024.

Revenue
−1.75%
EPS
+1.64%
Free cash flow
+118.8%
Total debt
−3.10%

Quarter to September 2026, against a year earlier

13.87 0.08 +0.58%
Market cap
$3.6B
P/E
17.3×
Fwd P/E
6.2×
Dividend yield
0.58%
F-score
5/9
ROIC
6.26%
Net debt / EBITDA
5.6×
Dividend safety
45/100

Organon & Co. (OGN) EV/FCF

Alert me on EV/FCF

As of 6 November 2026, Organon & Co. (OGN) trades at a EV/FCF of 18.8×. Over the past ten years it has ranged from 3.3× (June 2021) to 65.3× (July 2022); the current reading is higher than 41% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 23.9× 31.77%
FY2024 18.2× (30.41%)
FY2023 26.1× (7.28%)
FY2022 28.1× 244.89%
FY2021 8.2× 117.29%
FY2020 3.8× 0.00%
FY2019 3.8× 0.00%
FY2018 3.8× 0.00%
FY2017 3.8× —

Quarterly newest first

Period EV/FCF Change
Sep 2026 18.7× (20.95%)
Jun 2026 23.7× 46.99%
Mar 2026 16.1× (32.74%)
Dec 2025 23.9× 36.58%
23 more quarters

Against its own ten years

Low 3.3× High 65.3×
Ten-year median 20.3×
Current reading's percentile 41

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on OGN